Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05028140
PHASE3

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

Sponsor: EMS

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus

Official title: National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

480

Start Date

2024-10-08

Completion Date

2027-09

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

DRUG

PIEMONTE

Piemonte association 1 coated tablet once a day

OTHER

PIEMONTE PLACEBO

Placebo of Piemonte association 1 coated tablet once a day

DRUG

EMPAGLIFLOZIN

Empagliflozin 25 mg 1 coated tablet once a day

OTHER

PLACEBO EMPAGLIFLOZIN

Placebo of empagliflozin 25 mg 1 coated tablet once a day

DRUG

PIOGLITAZONE

Pioglitazone 30 mg 1 tablet once a day

OTHER

PLACEBO PIOGLITAZONE

Placebo of pioglitazone 30 mg 1 tablet once a day

Locations (1)

EMS

Hortolândia, São Paulo, Brazil